Polaris Venture Partners Special Founders' Fund V, L.p. - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Lyra Therapeutics Inc (LYRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lyra Therapeutics Inc (LYRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Lyra Therapeutics Inc (LYRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners Special Founders' Fund V, L.p. made no insider transaction in aTyr Pharma Inc (ATYR). Other recent insider transactions involving aTyr Pharma Inc (ATYR) include a net purchase of 2,156 shares made by Jill Marie Broadfoot , a net purchase of 35,000 shares made by Sanjay Shukla , and a net purchase of 4,101 shares made by Nancy Krueger .

In summary, during the past 3 months, insiders sold 0 shares of aTyr Pharma Inc (ATYR) in total and bought 3,750 shares, with a net purchase of 3,750 shares. During the past 18 months, 3,743 shares of aTyr Pharma Inc (ATYR) were sold and 198,750 shares were bought by its insiders, resulting in a net purchase of 195,007 shares.

aTyr Pharma Inc (ATYR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners Special Founders' Fund V, L.p. made no insider transaction in Ocular Therapeutix Inc (OCUL). Other recent insider transactions involving Ocular Therapeutix Inc (OCUL) include a net sale of 105,880 shares made by Pravin Dugel , a net sale of 8,880 shares made by , and a net sale of 30,065 shares made by Donald Notman .

In summary, during the past 3 months, insiders sold 42,940 shares of Ocular Therapeutix Inc (OCUL) in total and bought 10,000 shares, with a net sale of 32,940 shares. During the past 18 months, 253,403 shares of Ocular Therapeutix Inc (OCUL) were sold and 2,479,312 shares were bought by its insiders, resulting in a net purchase of 2,225,909 shares.

Ocular Therapeutix Inc (OCUL)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Dare Bioscience Inc (DARE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dare Bioscience Inc (DARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dare Bioscience Inc (DARE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners Special Founders' Fund V, L.p. made no insider transaction in Phreesia Inc (PHR). Other recent insider transactions involving Phreesia Inc (PHR) include a net sale of 112,299 shares made by David Linetsky , a net sale of 180,645 shares made by Evan Roberts , and a net sale of 93,354 shares made by Allison C Hoffman .

In summary, during the past 3 months, insiders sold 80,215 shares of Phreesia Inc (PHR) in total and bought 0 shares, with a net sale of 80,215 shares. During the past 18 months, 819,639 shares of Phreesia Inc (PHR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 819,639 shares.

Phreesia Inc (PHR)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Trevena Inc (TRVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Trevena Inc (TRVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Trevena Inc (TRVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners Special Founders' Fund V, L.p. made no insider transaction in Fate Therapeutics Inc (FATE). Other recent insider transactions involving Fate Therapeutics Inc (FATE) include a net purchase of 100,961 shares made by Redmile Group, Llc , a net sale of 19,976 shares made by Bahram Valamehr , and a net sale of 16,528 shares made by Cindy Tahl .

In summary, during the past 3 months, insiders sold 0 shares of Fate Therapeutics Inc (FATE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 408,018 shares of Fate Therapeutics Inc (FATE) were sold and 442,594 shares were bought by its insiders, resulting in a net purchase of 34,576 shares.

Fate Therapeutics Inc (FATE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners Special Founders' Fund V, L.p. made no insider transaction in Cartesian Therapeutics Inc (RNAC). Other recent insider transactions involving Cartesian Therapeutics Inc (RNAC) include a net purchase of 2,181,087 shares made by Timothy A Springer , a net sale of 1,797 shares made by , and a net sale of 17,271 shares made by Carsten Brunn .

In summary, during the past 3 months, insiders sold 0 shares of Cartesian Therapeutics Inc (RNAC) in total and bought 238,938 shares, with a net purchase of 238,938 shares. During the past 18 months, 278,198 shares of Cartesian Therapeutics Inc (RNAC) were sold and 1,006,048 shares were bought by its insiders, resulting in a net purchase of 727,850 shares.

Cartesian Therapeutics Inc (RNAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GNCAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GNCAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genocea Biosciences Inc (GNCAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners Special Founders' Fund V, L.p. made no insider transaction in Kala Bio Inc (KALA). Other recent insider transactions involving Kala Bio Inc (KALA) include a net sale of 54,610 shares made by Mark T Iwicki , a net sale of 15,241 shares made by Romulus K Brazzell , and a net sale of 13,534 shares made by Todd Bazemore .

In summary, during the past 3 months, insiders sold 32,389 shares of Kala Bio Inc (KALA) in total and bought 0 shares, with a net sale of 32,389 shares. During the past 18 months, 105,869 shares of Kala Bio Inc (KALA) were sold and 310,559 shares were bought by its insiders, resulting in a net purchase of 204,690 shares.

Kala Bio Inc (KALA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners Special Founders' Fund V, L.p. made no insider transaction in T2 Biosystems Inc (TTOO). Other recent insider transactions involving T2 Biosystems Inc (TTOO) include a net sale of 55 shares made by David B Elsbree ,

In summary, during the past 3 months, insiders sold 0 shares of T2 Biosystems Inc (TTOO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 55 shares of T2 Biosystems Inc (TTOO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 55 shares.

T2 Biosystems Inc (TTOO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners Special Founders' Fund V, L.p. made no insider transaction in X4 Pharmaceuticals Inc (XFOR). Other recent insider transactions involving X4 Pharmaceuticals Inc (XFOR) include a net sale of 451,076 shares made by Paula Ragan , a net sale of 111,687 shares made by Mary Dibiase , and a net sale of 385,639 shares made by Adam S. Mostafa .

In summary, during the past 3 months, insiders sold 0 shares of X4 Pharmaceuticals Inc (XFOR) in total and bought 1,032 shares, with a net purchase of 1,032 shares. During the past 18 months, 36,408 shares of X4 Pharmaceuticals Inc (XFOR) were sold and 2,200 shares were bought by its insiders, resulting in a net sale of 34,208 shares.

X4 Pharmaceuticals Inc (XFOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Pulmatrix Inc (PULM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pulmatrix Inc (PULM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Pulmatrix Inc (PULM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners Special Founders' Fund V, L.p. made no insider transaction in Cardlytics Inc (CDLX). Other recent insider transactions involving Cardlytics Inc (CDLX) include a net sale of 286,318 shares made by Amit Gupta , a net sale of 56,146 shares made by Nicholas Hollmeyer Lynton , and a net sale of 198,815 shares made by Alexis Desieno .

In summary, during the past 3 months, insiders sold 47,614 shares of Cardlytics Inc (CDLX) in total and bought 0 shares, with a net sale of 47,614 shares. During the past 18 months, 716,227 shares of Cardlytics Inc (CDLX) were sold and 1,733,207 shares were bought by its insiders, resulting in a net purchase of 1,016,980 shares.

Cardlytics Inc (CDLX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners Special Founders' Fund V, L.p. made no insider transaction in Invivyd Inc (IVVD). Other recent insider transactions involving Invivyd Inc (IVVD) include a net sale of 1,733,703 shares made by Terrance Mcguire , and a net sale of 5,000,000 shares made by Adimab, Llc .

In summary, during the past 3 months, insiders sold 0 shares of Invivyd Inc (IVVD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,733,703 shares of Invivyd Inc (IVVD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,733,703 shares.

Invivyd Inc (IVVD)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GGNNQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GGNNQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genocea Biosciences Inc (GGNNQ)'s detailed insider trading history can be found in Insider Trading Tracker table.